Sino Biopharmaceutical Forms Indonesia Joint Venture With Tempo ScanTip Ranks·Jul 27 at 04:11 AM01177-0.59%
Sino Biopharmaceutical (SBMFF) Receives a Buy from UOB Kay HianTip Ranks·Jul 25 at 09:55 AM01177-0.59%
Sino Biopharm Wins NMPA Nod for Innovative Hepatitis B Drug TrialTip Ranks·Jul 23 at 05:09 AM01177-0.59%GSK-0.49%
Sino Biopharm says China NMPA clears IM-101 hepatitis B drug for clinical trialPUBT·Jul 23 at 04:44 AM01177-0.59%
Citi Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)Tip Ranks·Jul 22 at 07:26 PM01177-0.59%
‘Systemic leap’: China’s drug innovation push yields bumper cropSCMP·Jul 20 at 06:03 PM02171+4.36%688192-0.22%
M Stanley Adjusts SBP GROUP 2026-28 EPS Forecasts, Reiterates "Overweight"AASTOCKS News·Jul 13 at 10:41 PM01177-0.59%GSK-0.49%
Sino Biopharm files HKEX next-day return disclosing share buyback cancellation at HKD 4.46 eachPUBT·Jul 13 at 03:19 AM01177-0.59%
Sino Biopharmaceutical (SBMFF) Receives a Buy from BOCOM International Holdings CompanyTip Ranks·Jul 11 at 09:35 AM01177-0.59%
Sino Biopharm says China regulator accepts NDA for TQB3454 IDH1 inhibitor in biliary tract cancerPUBT·Jul 10 at 04:00 AM01177-0.59%
CMB International Securities Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)Tip Ranks·Jul 10 at 12:15 AM01177-0.59%
Why Sino Biopharmaceutical (SEHK:1177) Is Up 8.2% After New Global Respiratory Deals And NDA MilestoneSimplywall·Jul 9 at 07:16 PM01177-0.59%AZN-0.66%
Sino and AstraZeneca sign licence agreement for TQC3721Pharmaceutical Technology·Jul 9 at 04:48 AMAZN-0.66%AZN
